Company intelligence / Profile preview

Frosst Ibérica

Alcalá de Henares, Madrid, Spain

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Frosst Ibérica was a major Spanish pharmaceutical manufacturer and a key subsidiary of Merck Sharp & Dohme (MSD). Located in Alcalá de Henares, the company specialized in the large-scale production of solid oral dosage forms, including blockbuster medications for cardiovascular and respiratory conditions. In 2010, as part of a global supply chain restructuring following the Merck-Schering-Plough merger, the facility was sold to Mylan. The site continues to operate under Viatris, while the Frosst Ibérica brand remains a significant part of Spain's industrial pharmaceutical history.

Therapeutic areas: EndocrinologyCardiovascularPulmonology
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Frosst Ibérica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frosst Ibérica.

Explore the full profile